AI assistant
Sending…
BIO-RAD LABORATORIES, INC. — Director's Dealing 2008
Jun 13, 2008
30786_dirs_2008-06-13_d3ecdde2-37f3-447d-a4af-7776d2f85ffe.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO RAD LABORATORIES INC (BIO, BIO.B)
CIK: 0000012208
Period of Report: 2008-06-11
Reporting Person: SCHWARTZ NORMAN D (Director, CEO, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2008-06-11 | Bio-Rad B Common Stock | A | 12500 | — | Acquired | 76574 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2008-06-11 | Non-Qualified Stock Option (right to buy) | $88.48 | A | 37500 | Acquired | 2018-06-11 | Bio-Rad B Common Stock (37500) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Bio-Rad A Common Stock | 211454 | Direct |
| Bio-Rad B Common Stock | 363440 | Indirect |
| Bio-Rad B Common Stock | 13726 | Indirect |
| Bio-Rad B Common Stock | 11200 | Indirect |
Footnotes
F1: The shares are held by a limited partnership of which the reporting person is a general partner.
F2: The shares are held by a limited partnership of which the reporting person is a limited partner.
F3: The reporting person disclaims beneficial ownership of these shares.
F4: The stock option vests over five years at 20% per year on the yearly anniversary date of the grant.
More from BIO-RAD LABORATORIES, INC.
Regulatory Filings
2026
May 13
Share Issue/Capital Change
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Earnings Release
2026
Apr 30
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Regulatory Filings
2026
Feb 19
Annual Report
2026
Feb 13